Cargando…
Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model
Various combination treatments have been considered to attain the effective therapy threshold by combining independent antitumor mechanisms against the heterogeneous characteristics of tumor cells in malignant brain tumors. In this study, the natural killer (NK) cells associated with bevacizumab (Be...
Autores principales: | Tran, Thi-Anh-Thuy, Kim, Young-Hee, Duong, Thi-Hoang-Oanh, Thangaraj, JayaLakshmi, Chu, Tan-Huy, Jung, Shin, Kim, In-Young, Moon, Kyung-Sub, Kim, Young-Jin, Lee, Tae-Kyu, Lee, Chul Won, Yun, Hyosuk, Lee, Je-Jung, Lee, Hyun-Ju, Lee, Kyung-Hwa, Jung, Tae-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871756/ https://www.ncbi.nlm.nih.gov/pubmed/36703992 http://dx.doi.org/10.3389/fimmu.2022.1009484 |
Ejemplares similares
-
Peptide Vaccine Combined Adjuvants Modulate Anti-tumor Effects of Radiation in Glioblastoma Mouse Model
por: Tran, Thi-Anh-Thuy, et al.
Publicado: (2020) -
The long multi-epitope peptide vaccine combined with adjuvants improved the therapeutic effects in a glioblastoma mouse model
por: Tran, Thi-Anh-Thuy, et al.
Publicado: (2022) -
Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99
por: Kim, Young-Hee, et al.
Publicado: (2016) -
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model
por: Thangaraj, Jaya Lakshmi, et al.
Publicado: (2022) -
Bevacizumab-refractory radiation necrosis with pathologic transformation of benign meningioma following adjuvant gamma knife radiosurgery: A rare case report
por: Kim, You-Sub, et al.
Publicado: (2020)